Selank is a synthetic heptapeptide built on the same construction principle as Semax: take a short natural fragment that is degraded too quickly to study, and bolt a stabilising tail onto it. The two compounds come from the same research programme and share that tail exactly. What they do not share is the fragment — and that difference is the whole of the distinction between them.
SOMA Research supplies Selank for laboratory research use only. It is not a drug, supplement, food or cosmetic, is not approved by the FDA for any use, and is not intended for human or veterinary consumption.
What Selank is
- Sequence: Thr-Lys-Pro-Arg-Pro-Gly-Pro (TKPRPGP)
- CAS number: 129954-34-3
- Molecular formula: C33H57N11O9
- Molecular weight: approximately 751.9 g/mol
- Length: 7 amino acids
- Appearance: white lyophilised powder
The first four residues — Thr-Lys-Pro-Arg — are tuftsin, a naturally occurring tetrapeptide. The last three are Pro-Gly-Pro, the stabilising motif.
Tuftsin is not a hormone fragment
This is where Selank parts company with the other fragment-derived peptides in the catalogue. Tuftsin is a fragment of the heavy chain of immunoglobulin G — an antibody, not a hormone. It is released from the Fc region, and its literature sits in immunology rather than endocrinology.
Set the three fragment-based compounds side by side and the pattern is clear:
| Compound | Active fragment | Parent molecule | Stabilising tail |
|---|---|---|---|
| Semax | ACTH(4–7) | Adrenocorticotropic hormone | Pro-Gly-Pro |
| KPV | α-MSH(11–13) | Melanocyte-stimulating hormone | none |
| Selank | Tuftsin | Immunoglobulin G heavy chain | Pro-Gly-Pro |
Semax and KPV are both POMC-derived — two fragments of the same hormone precursor family. Selank is from an entirely different protein lineage and arrives at a similar place by a different route. For comparative work this matters: Semax and Selank look like siblings because they share a tail and an origin laboratory, but their active fragments have nothing in common.
What Pro-Gly-Pro does
Tuftsin on its own is a tetrapeptide and is cleaved rapidly by exopeptidases. The Pro-Gly-Pro extension hinders access to the C-terminus: proline’s ring constrains the backbone and is poorly tolerated by many peptidases, and the glycine between the two prolines supplies the flexibility the motif needs to adopt its conformation. The result is a peptide that survives long enough to be studied.
Because Semax carries the identical tail, a panel containing both holds the stabilising motif constant. Any difference observed between them is attributable to the fragment, not to the tail — which is a cleaner comparison than most peptide pairs allow.
What the published research examines
Selank was developed at the Institute of Molecular Genetics in Russia, and as with Semax a large share of the primary literature is Russian-language or Russian-origin. That limits independent replication and English-language review, and it is relevant context when weighing the evidence. The recurring threads:
- Anxiolytic-like behaviour in rodent models. The most frequently reported thread, using standard behavioural paradigms.
- Monoamine metabolism. Work examining serotonin and related neurotransmitter systems in animal tissue.
- BDNF expression. Reported changes in brain-derived neurotrophic factor in rodent brain tissue, overlapping with the Semax literature.
- Immunomodulatory activity. Following from the tuftsin origin, a separate strand examines immune-cell effects — the thread that has no counterpart in the Semax literature.
- Enkephalin degradation. Studies on effects on enkephalin-degrading enzyme activity in plasma.
Selank holds a regulatory registration in the Russian Federation for certain indications. That registration is specific to that jurisdiction and to a pharmaceutical product made for it. It is not an FDA approval and does not extend to research-grade material, which carries no approval in any jurisdiction.
Analytical characterisation
- HPLC purity. Reversed-phase separation from deletion sequences and synthesis-related impurities, reported as a percentage of total peak area.
- Mass spectrometry. Identity confirmation against approximately 751.9 g/mol.
- A contrast with Semax worth knowing. Semax carries an N-terminal methionine, which oxidises readily to the sulphoxide and adds 16 Da — its most common degradation product. Selank has no methionine and no cysteine, so that particular failure mode does not apply. Selank is the more forgiving of the two on storage, and a +16 Da species on a Selank trace should not be explained away as routine methionine oxidation, because there is no methionine to oxidise.
- Arginine and the counter-ion. The arginine residue is strongly basic, so the material is typically supplied as a salt and the counter-ion contributes to the weighed mass. Read peptide content separately from HPLC purity; the Certificate of Analysis guide covers the distinction.
Every SOMA lot is tested by third-party laboratories using both methods, with measured figures published per lot in our CoA library.
Variants
N-Acetyl Selank and N-Acetyl Selank amidate circulate alongside the base peptide. Each modification changes the molecular weight, so a CoA for a variant reports a different mass than 751.9 g/mol. When comparing published results, check which form a study used; secondary sources frequently blur the distinction, and a molarity calculation performed with the wrong mass inherits the error.
Handling and storage
- Lyophilised powder: -20°C, protected from light.
- Reconstituted stock: 2–8°C, aliquoted, used within approximately 30 days.
- Avoid freeze-thaw cycling.
- No special oxidation precautions beyond good practice, for the reason given above — this is one of the easier peptides in the catalogue to store.
The procedure and the concentration arithmetic are in our reconstitution guide.
Related guides
Research use only
Research-grade Selank is supplied for laboratory use by qualified researchers and institutions. It is not manufactured to pharmaceutical standards, has not been approved by the FDA for any use, and must not be used in or on humans or animals. Nothing in this guide is medical advice or a representation that the compound is safe or effective for any purpose.
